English | Español

Novartis
Patient Daily | May 7, 2023

Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
Patient Daily | May 7, 2023

Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO
Patient Daily | May 7, 2023

Novartis Phase III APPOINT-PNH trial shows investigational oral monotherapy iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naïve PNH patients
Patient Daily | May 7, 2023

Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidance
Carol Ostrow | Feb 7, 2019

Novartis says Cosentyx better at clearing skin in psoriasis patients than Stelara
Press release submission | Dec 5, 2018

NOVARTIS: Announces longer-term analyses from pivotal Kymriah® trials that showed durable responses are maintained in patients with advanced blood cancers
Press releases submission | May 15, 2018

NOVARTIS: Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally
Carrie Bradon | Dec 1, 2017

Novartis announces positive results of MONALEESA-7 trial

Trending
+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas
Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval